Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.28 million which missed the analyst consensus estimate of $3.70 million by 38.34 percent. This is a 10.75 percent decrease over sales of $2.56 million the same period last year.